The Chennai facility will manufacture high-quality medical tubing for neurovascular and cardiovascular applications, including balloon catheters and other minimally invasive devices
Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The device will facilitate the treatment of cerebral vasospasm following hemorrhagic stroke
Over the next few years, Philips aims to double the number of its active cath labs in India with a special focus on improving accessibility to quality cardiac and neurovascular care in tier 2 and tier 3 cities
Subscribe To Our Newsletter & Stay Updated
